MXPA01010186A - Composiciones y metodos para el tratamiento y diagnostico de cancer de mama. - Google Patents

Composiciones y metodos para el tratamiento y diagnostico de cancer de mama.

Info

Publication number
MXPA01010186A
MXPA01010186A MXPA01010186A MXPA01010186A MXPA01010186A MX PA01010186 A MXPA01010186 A MX PA01010186A MX PA01010186 A MXPA01010186 A MX PA01010186A MX PA01010186 A MXPA01010186 A MX PA01010186A MX PA01010186 A MXPA01010186 A MX PA01010186A
Authority
MX
Mexico
Prior art keywords
breast cancer
compositions
treatment
methods
diagnosis
Prior art date
Application number
MXPA01010186A
Other languages
English (en)
Spanish (es)
Inventor
Tony N Frudakis
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/289,198 external-priority patent/US6586570B1/en
Priority claimed from US09/429,755 external-priority patent/US6656480B2/en
Priority claimed from US09/534,825 external-priority patent/US6861506B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of MXPA01010186A publication Critical patent/MXPA01010186A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5154Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MXPA01010186A 1999-04-09 2000-04-07 Composiciones y metodos para el tratamiento y diagnostico de cancer de mama. MXPA01010186A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/289,198 US6586570B1 (en) 1996-01-11 1999-04-09 Compositions and methods for the treatment and diagnosis of breast cancer
US09/429,755 US6656480B2 (en) 1996-01-11 1999-10-28 Compositions and methods for the treatment and diagnosis of breast cancer
US09/534,825 US6861506B1 (en) 1996-01-11 2000-03-23 Compositions and methods for the treatment and diagnosis of breast cancer
PCT/US2000/009312 WO2000061753A2 (en) 1999-04-09 2000-04-07 Compositions and methods for the treatment and diagnosis of breast cancer

Publications (1)

Publication Number Publication Date
MXPA01010186A true MXPA01010186A (es) 2004-08-12

Family

ID=27403868

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01010186A MXPA01010186A (es) 1999-04-09 2000-04-07 Composiciones y metodos para el tratamiento y diagnostico de cancer de mama.

Country Status (15)

Country Link
EP (1) EP1169444A2 (cs)
JP (1) JP2002541803A (cs)
KR (1) KR20020026418A (cs)
CN (1) CN1352683A (cs)
AU (1) AU774824B2 (cs)
BR (1) BR0009573A (cs)
CA (1) CA2365909A1 (cs)
CZ (1) CZ20013575A3 (cs)
HU (1) HUP0200825A2 (cs)
IL (1) IL145719A0 (cs)
MX (1) MXPA01010186A (cs)
NO (1) NO20014805L (cs)
NZ (1) NZ514646A (cs)
PL (1) PL350863A1 (cs)
WO (1) WO2000061753A2 (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828431B1 (en) 1999-04-09 2004-12-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6656480B2 (en) 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6586570B1 (en) 1996-01-11 2003-07-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6861506B1 (en) 1996-01-11 2005-03-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US20020068285A1 (en) * 1996-01-11 2002-06-06 Frudakis Tony N. Compositions and methods for the therapy and diagnosis of breast cancer
US20030125536A1 (en) * 1996-01-11 2003-07-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
CN111983220B (zh) * 2019-05-21 2024-03-19 北京中科纳泰生物科技有限公司 多肽磁性纳米颗粒、其制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1575697A (en) * 1996-01-10 1997-08-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of cancer
EP1876241A3 (en) * 1996-01-11 2008-07-30 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
ZA982968B (en) * 1997-04-09 1998-10-27 Corixa Corp Compositions and methods for the treatment and diagnosis of breast cancer
AU758004B2 (en) * 1997-12-17 2003-03-13 Genset S.A. Extended cDNAs for secreted proteins
CZ2001149A3 (cs) * 1998-07-14 2002-02-13 Corixa Corporation Prostředky a způsoby pro terapii a diagnostiku karcinomu prostaty

Also Published As

Publication number Publication date
CN1352683A (zh) 2002-06-05
AU4213000A (en) 2000-11-14
EP1169444A2 (en) 2002-01-09
HUP0200825A2 (en) 2002-07-29
NO20014805L (no) 2001-12-06
BR0009573A (pt) 2002-04-16
CZ20013575A3 (cs) 2002-10-16
CA2365909A1 (en) 2000-10-19
JP2002541803A (ja) 2002-12-10
NO20014805D0 (no) 2001-10-03
PL350863A1 (en) 2003-02-10
NZ514646A (en) 2005-04-29
KR20020026418A (ko) 2002-04-10
WO2000061753A2 (en) 2000-10-19
IL145719A0 (en) 2002-07-25
WO2000061753A3 (en) 2001-06-28
AU774824B2 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
WO1997025426A3 (en) Compositions and methods for the treatment and diagnosis of breast cancer
WO1998045328A3 (en) Compositions and methods for the treatment and diagnosis of breast cancer
HUP0203035A2 (hu) Prosztatarák terápiájára és diagnózisára alkalmas vegyületek és eljárások
IL145731A0 (en) A polypetide containing an immunogenic portion of a breast tumor protein and pharmaceutical compositions containing the same
HUP0203968A2 (hu) Készítmények és eljárások prosztatarák terápiájára és diagnózisára
NO20004631L (no) Forbindelser og fremgangsmÕter for terapi og diagnose av lungekreft
WO1999033869A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
MXPA03001634A (es) Polipeptido tumoral cripto.
WO2003087831A3 (en) Proteins involved in breast cancer
ZA200409492B (en) Compositions and methods for the diagnosis and treatment of tumor.
WO2000061756A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
MXPA01010186A (es) Composiciones y metodos para el tratamiento y diagnostico de cancer de mama.
WO2001018046A3 (en) Ovarian tumor sequences and methods of use therefor
WO2001071357A3 (en) Diagnosis and treatment of breast cancer
AU5947701A (en) Methods for identification, diagnosis, and treatment of breast cancer
AU2001233913A1 (en) Bcmp 84, a protein associated to breast cancer
ATE514780T1 (de) Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon
GB0305422D0 (en) Detection, monitoring and treatment of cancer
WO2003013431A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
IL207012A (en) 28sgp medicinal product and 28sgp accent cancer treatment vaccine
MXPA02011563A (es) Composicionesy metodos para la terapia y diagnostico de cancer de seno.
WO1999037775A3 (en) Compositions and methods for detecting and treating breast cancer
ZA200108256B (en) Compositions and methods for the treatment and diagnosis of breast cancer.
WO2004005349A3 (en) Preparation based on an antibody directed against a tumor-associated glycosylation such as lewis structures
DE60326931D1 (de) In kanzerösen mammazellen differentiell exprimierte genprodukte und ihre verwendungsverfahren

Legal Events

Date Code Title Description
FA Abandonment or withdrawal